To evaluate the usefulness of intravenous patient-controlled analgesia (PCA) fentanyl for labour analgesia, its effectiveness for maternal pain and safety for the fetus and newbom.
E
PIDURAL blockade is known to be effective and safe in labour pain treatment. There are, however, situations when it is contraindicated, for example infections or bleeding disorders. In many hospitals anaesthesia services and epidural blockade are not available 24 hr a day. Also, it has been suggested that epidural blockade in labour is associated with increased maternal intrapartum fever and neonatal sepsis requiring antibiotic treatment. ~ Therefore, alternatives for labour analgesia are needed.
Parenteral medication offers an option for these situations. In a survey of 17 European countries im meperidine was the most common method of providing labour analgesia. 2 Yet, the effectiveness of meperidine is limited, 3 and it is associated with many harmfial fetal and neonatal effects. ~12 Morphine has also been used in labour analgesia, but the results are poor. It has very limited analgesic effects and causes maternal sedation. 13 Of the other opioids, fentanyl has some qualities that make it a promising candidate for obstetric use. It has a rapid onset and short duration of action, 14 and it lacks active metabolites) s The elimination half-life in normal neonates varies between 75 and 440 min. 16 Fentanyl has proved to be suitable for neonatal anaesthesia. 17 Possible harmful effects can easily be reversed with naloxone. 18 Fentanyl has also been used ha labour. It has no adverse effects on uterine tone or blood flow. 19 When given by hourly iv injections of 50-100 pg for labour analgesia there was no increase in the incidence of respiratory depression or low APGAR scores. Furthermore, neonatal neurological and adaptive capacities at 2 and 24 hr after delivery were normal. 2~ Only a brief decrease in fetal heart rate variability was reported. In a randomised comparison of fentanyl and meperidine for labour analgesia, the need for naloxone was less after fentanyl, although there were no differences in neurobehaviour at 2 and 24 hr postpartum. 2~ The authors concluded that fentanyl was preferable to meperidine.
Intravenous fentanyl PCA has been used in obstetrics. 22,2s The advantages of PCA method include a lower dose of opioids, and that mother has control over her pain management. 24 Randomised studies on PCA fentanyl in labour have not been published.
The purpose of this retrospective, randomised study was to evaluate the usefulness of iv PCA fentanyl for labour pain in a small number of mothers. The efficacy of fentanyl for maternal pain relief and its safety for the fetus and newborn were assessed.
Materials and methods
After local committee approval and written informed consent, 20 healthy primigravidas were studied when they arrived at the hospital in labour. Inclusion criteria were age 20-35 yr and weight <100 kg before pregnancy. Exclusion criteria were complications of pregnancy, regular use of drugs or chronic diseases.
When the mothers asked for pain relief, they were randomised to receive either iv fentanyl (n = 10) or epidural block (n = 10). In the fentanyl group a loading dose of 50 pg fentanyl was initially injected. Then, a patient-controlled pump (Graseby 3300) was set to deliver bolus doses of 20 pg fentanyl with a lock-out period of five minutes. The maximum dose in one hour was 240 pg. If the iv fentanyl was ineffective, epidural analgesia was offered. Bupivacaine 0.5% was used in the epidural group. Initially, 6 ml were injected between T12-L 1. On request, additional 4 ml doses were given via the epidural catheter. 2s For safety reasons, in this initial study, we did not treat pain ha the second stage of labour with iv fentanyl. In our hospital epidural analgesia is also not routinely given in the second stage.
Maternal heart rate and arterial oxyhaemoglobin saturation (SpO2) were continuously monitored with the oximeter attached to a finger (Datex Satlite). Pain relief was rated every 30 rain by the patient using a 100 mm long ungraded visual analog scale (VAS). Side-effects (sedation, nausea, vomiting, respiratory depression, other) were registered with a four graded scale (none, mild, moderate, severe).
In addition to routine monitoring, fetal cardiotocogram (CTG) was monitored twice, for 30 min, using a computerised system for antenatal fetal heart rate analysis (System 800026). It was recorded before and one hour after pain relief was started. In addition, the CTG signals were visually analysed by two independent obstetricians, who were not familiar with any clinical data of the patients.
Umbilical artery and vein blood samples were drawn immediately after delivery for plasma fentanyl determinations. Each sample was centrifuged and stored at -20~ until the time of assay. The samples were assayed in duplicate by radio immunoassay technique using commercially available kits (Diagnostic Products Corporation, Los Angeles, USA). The sensitivity of the assay was 0.08 ng.m1-1, the intra-assay variability was <4% and the interassay variability <7%. Umbilical artery and vein pH values were also analysed.
APGAR scores at 1, 5 and 15 min were assessed by delivery room personnel. At the age of one hour each infant had a neurological capacity scoring 27 performed by one of the authors (EN). Passive and active tone, primary reflexes and general assessment were scored (maximum 30).
From the age of one hour the babies rested for 12 hr on the static-charge-sensitive bed (SCSB) (Biomat, Biorec Inc., Turku, Finland). The SCSB consists of a mattress-like movement sensor placed in a normal bed. It has three static-charge layers. The original movement signal is preamplified and filtered into three separate signals. These three signals are body movements, respiratory movements and ballistocardiogram. The SCSB method is noninvasive, and it allows continuous and long-term monitoring of the neonate, zs
Together with SCSB monitoring, ECG and SpO 2 were continuously measured for 12 hr. The oximeter (Ohmeda Biox 3700e) probe was attached around the foot of the baby. The recordings took place on a newborn ward, in a normal nursery room. The SCSB recordings were stored on diskettes and printed and blindly scored afterwards by one of the authors (EN), using software developed for the SCSB recordings (BRll, Biorec Inc., Turku, Finland). The different sleep stages (awake, active sleep, intermediate sleep and quiet sleep) were scored according to criteria published by Alihanka. 19 The neurological capacity scoring was repeated at the end of the recording, i.e., at approximately 13 hr.
The day after delivery, mothers were asked about the overall effectiveness of their pain relief, using a scale poor, moderate, good and excellent. Mothers who had received both iv fentanyl and epidural analgesia gave their opinion of each separately.
Statistical calculations were done using the Minitabstatistical software (Release 10, State College, PA, USA). Student's t test was used for normally distributed data. Pain data were analysed using a two-way repeated measures analysis of variance. Oxygen saturation distributions as well as dichotomic subjective assessments were calculated using a Chi squared test. A P value of 0.05 was considered statistically significant.
Assuming a clinically significant decrease in breathing frequency (primary endpoint variable) from 25 to 22 and a SD of 2 the power of our analysis should be 90% with a group size of 10. venous fentanyl). In the epidural group, five mothers received one epidural top-up and one mother had two top-ups (at cervical dilatation 6-9 cm). Mothers who received both iv fentanyl and epidural analgesia did not require epidural top-ups. Demands from the PCApump are summarised in Table I . Maternal heart rate was regular and SpO 2 was 295% in every subject throughout labour and delivery. Subjective opinions about the pain relief are presented in Table II . The VAS for maternal pain up to one hour resulted in a time x treatment interaction (P = 0.01): initially, epidurai blockade was more effective than fentanyl PCA. The overall effectiveness of fentanyl PCA and epidural blockade did not differ between groups.
Results
Maternal weight at labour did not differ between (Table III) . Tiredness and dizziness were the most common and all side-effects were mild or moderate. One mother in the fentanyl group mad four in the epidural group had no side-effects.
There were no differences in overall variability of CTG between the two groups either before pain relief or one hour later. The overall variability before pain relief was 39.1 • 6.9 msec in the fentanyl group and 44.5 • 11.8 msec in the epidural group (normal >30 msec). One hour after pain relief the values were 43.4 • 12.1 and 45.1 • 20.6 msec, respectively. In the visual analysis of CTG no drug related changes were seen either.
Fentanyl was detectable in umbilical blood in five of the ten newborns. Concentrations varied between 0.10 and 0.66 ng.rul q. Arterial concentrations were 0.10 • 0.21 ng.m1-1 and venous 0.13 • 0.20 ng.ml q.
The data on the delivery outcomes are presented in Table IV . The indications for instrumental delivery were either prolonged second stage of labour or suspected fetal asphyxia. All babies were healthy at birth: none was asphyxiated or needed intensive care. Naloxone was not used. The APGAR scores, umbilical blood pH values and the results of Amiel-Tison's neurological capacity scoring did not differ either at the age of one or 13 hr.
In the fentanyl group, babies demonstrated more active sleep and less quiet and intermediate sleep and fewer awake periods than did the epidural group, but the differences were not statistically significant. Heart rate in the fentanyl group newborns was 120 + 7 bpm and 120 + 8 bpm in the epidural group during the whole recording. The same values for breathing frequency were 25 • 3 and 25 • 2 per min. During different sleep stages there were no differences between groups. No time-dependent trends were seen in heart rate, breathing frequency or in the amplitude of breathing. The movement time in the fentanyl group babies was 7 • 5% and in the epidural group babies 7 • 3% of the recording time.
The minimum and the maximum oxygen saturation values were lower in the fentanyl group infants (P < 0.001, Figure 2) , and the occurrence of SpO z <90% was more numerous in the fentanyl group (P < 0.05). Episodes of desaturation < 80% were rare and similar in frequency ha both groups. None of the babies received oxygen supply during the monitoring period.
Babies whose mothers received only iv fentanyl did not differ from those who had received both fentanyl and epidural for pain relief. Neonatal variables did not correlate with the total fentanyl dose or with the interval between the last fentanyl dose and delivery. Also, epidural blockade is unlikely to cause neonatal effects similar to opioids. Therefore, mothers and babies who received both fentanyl and epidural were analysed in the fentanyl group.
Discussion
In this randomised study we evaluated the effectiveness and safety of iv fentanyl PCA for labour analgesia compared with epidural block. Epidural analgesia proved to be superior in effectiveness. Nevertheless, more than half of the patients in the fentanyl group were comfortable with PCA fentanyl, which suggest that fentanyl has some potential ha relieving labour pain. In neonates we did not find any serious opioid-related effects, but SpO z was lower in the fentanyl group of babies during 12 hours monitoring.
All mothers in the study were nulliparous and had relatively long labours. This mode of analgesia might be more useful in multiparas who, generally, have shorter labours. Although there were more maternal side-effects in the fentanyl group, these were mild or moderate. No serious side-effects were seen.
For the fetal well-being we did not find any harmful effects of fentanyl PCA, as no changes were detected in CTG recordings. This differs from a previous study by Rayburn et al., 2~ who reported a brief decrease in fetal heart rate variability after iv fentanyl in labour. All the newborns in this study were healthy and vigorous at birth. None of the babies needed naloxone. The APGAR scores and umbilical pH values were similar in both groups. Also, the neurological capacity scoring was identical between groups: no drug-related effects were seen. These variables did not show any harmful fetal or neonatal effects of iv fentanyl. The umbilical cord fentanyl concentrations in this study were low or beyond the detection limit of the assay. This further explains the absence of any gross opioid-linked signs in the newborns. No correlation was found between fentanyl concentrations and status of the newborn. The total fentanyi dose did not correlate with the neonatal status either. The lack of correlation may be due to the greatly variable elimination capacity of fentanyl in the newborns. I6,3~ Also, the time between the last fentanyl bolus and delivery was quite long. Probably, the short-acting fentanyl had been largely eliminated from the fetus and umbilical cord before delivery.
When systemic opioids are used during labour, neonatal monitoring is important due to the potential side-effects of those drugs. The SCSB method was used in an attempt to detect sub-clinical drug-related effects. We had expected to see lower breathing frequency, less motor activity and more sleep in babies receiving fentanyl. The SCSB method was originally developed for adults, 28 but it has proved to be useful for infant recordings. 31-34 The SCSB method has also been used in pharmacological studies. 3~
The 12 hr monitoring of newborns revealed some differences between the clinically similar babies. There were differences in the distribution of sleep stages, although these were not statistically significant. In the fentanyl group we found more active sleep than in the epidural group. Also, the fentanyl group babies had less awake periods and less quiet and intermediate sleep than controis. Opioids have previously shown to decrease quiet sleep and increase active sleep in human newborns. 36, 37 It is now accepted that newborns and, perhaps, fetuses feel pain. 38,39 Fetal and neonatal pain and stress are said to be related to an increased amount of quiet sleep. 4~ Therefore, babies with less pain and stress during delivery may have less quiet sleep after birth. Also, fentanyl prevents the biochelrfical and endocrine stress responses to painful stimuli during surgical operations in newborn infants. 42 Therefore, another hypothesis for the decreased amount of quiet sleep in the fentanyl group babies could be the diminished delivery stress and pain of the fetus and newborn baby.
With larger group sizes the differences in sleep stages may have become statistically significant. The clinical importance of sleep stage changes and whether those changes have any benefits or disadvantages for the newborn baby are unknown.
The SpO2, both minimum and maximum values, was lower in the fentanyl group of babies. The fentanyl neonates had more events of SpO 2 <90%, most of which were brief. Desaturation <80% was rare in both groups. Although the newborns in our study were clinically healthy and rtaloxone was not needed, the differences in oxygenation are disturbing. Fortunately, desaturation is easy to detect with SpO 2 monitors and easy to treat with naloxone. We were surprised that fentanyl did not to affect respiratory rate.
All the mothers in this study were healthy women with normal term pregnancies and all the newborns appeared to be healthy. Even in this normal material some desaturation occurred. If combined with other compromising factors iv fentanyl might have more serious effects for the newborn. Therefore, when iv fentanyl is given to mothers in labour, the newborn oxygenation should be monitored after birth. Also, naloxone should be available if severe desaturation occurs.
We monitored the babies for 12 hr and desaturation events occurred throughout this period. Therefore, in clinical practice, monitoring of the babies for several hours is recommended. Nowadays the pulse oximeters are small and movable, and there is no need to separate the babies and mothers due to SpO 2 measurement.
The group sizes in this study were small, because we had anticipated that the differences between the groups would be more obvious. The study was time consuming, and we wanted to avoid unnecessarily separating babies from their mothers. A larger clinical study is needed to establish the safety of fentanyl dosing. Even with this group size, a 10% decrease in breathing frequency of the babies should have been distinguishable with a 90% power.
In conclusion, iv fentanyl can be used to provide labour analgesia in some situations, as an alternative to epidural blockade. With the doses used in this study fentanyl had an effect on maternal pain, but only some mothers was satisfied with the pain relief. For the fetus and baby there are potential risks but, in healthy babies we did not see any serious side-effects or need for naloxone. When fentanyl is used the fetus and newborn must be appropriately monitored. Also, naloxone and oxygen should be available if serious neonatal distress occurs. The SCSB method appeared applicable for the detection of neonatal drug effects, but in clinical practice the SpO 2 monitoring is sufficient.
